Evidence map›Paper›PMID 33809511›Full record

ArticleMolecules (Basel, Switzerland)2021

Optimization, Validation and Application of HPLC-PDA Methods for Quantification of Triterpenoids in

Gabriele Vilkickyte, Lina Raudone

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Profiling and cheminformatics bioprospection of curcurbitacin I and momordin Ic fromJournal of enzyme inhibition and medicinal chemistry · 2025
    Article
  3. Article
  4. Comparative Phytoprofiling ofPlants (Basel, Switzerland) · 2024
    Article
  5. Review
  6. Article
  7. Article
  8. Fractionation and Characterization of Triterpenoids fromAntioxidants (Basel, Switzerland) · 2023
    Article
  9. Article
  10. Foods (Basel, Switzerland) · 2021
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Gabriele VilkickyteLaboratory of Biopharmaceutical Research, Institute of Pharmaceutical Technologies, Lithuanian University of Health Sciences, Sukileliu av. 13, LT-50162 Kaunas, Lithuania.ORCID 0000-0002-6125-8844
Lina RaudoneLaboratory of Biopharmaceutical Research, Institute of Pharmaceutical Technologies, Lithuanian University of Health Sciences, Sukileliu av. 13, LT-50162 Kaunas, Lithuania.ORCID 0000-0002-7324-0043
Lithuanian University of Health Sciences · LT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Triterpenoids have regained much attention as promising multi-targeting bioactive agents of natural origin in the treatment of numerous disorders. Due to the high potential for phytopharmaceutical development, accurate qualitative and quantitative analysis of triterpenoids for screening and quality control is required.

Indexed as

Chromatography, High Pressure LiquidFlowersFruitPentacyclic TriterpenesPlant ExtractsPlant LeavesQuality ControlTriterpenesUrsolic AcidVaccinium myrtillusVaccinium vitis-idaeaalpha-amyrinPentacyclic TriterpenesPlant ExtractsTriterpenesUrsolic AcidHPLCtriterpenoidsVaccinium vitis-idaea L.validation

Identifiers

PMID33809511
PMCPMC8001753
OpenAlexW3139268435

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.